Embla Medical: Recording of FY 2025 results presentation
Today, Embla Medical’s CEO, Sveinn Sölvason, presented the FY 2025 results and outlined the key drivers behind the expectations for 2026. These expectations underline a stable structural growth case and are well aligned with the company’s mid-term 2027 targets.
During the Q&A session, the focus was on what could lift results to the upper end of the 2026 guidance, and whether the improving momentum in the Patient Care business—a key earnings part of reaching the high end, can be sustained into 2026.
You can watch a recording of the presentation here:
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Digital IR agreement. /Michael Friis 15:00, 03/02/2026.
